{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T19:58:03Z","timestamp":1792699083630,"version":"4.5.0"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82171102"],"award-info":[{"award-number":["82171102"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32430018"],"award-info":[{"award-number":["32430018"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Biotechnol"],"DOI":"10.1038\/s41587-026-03227-9","type":"journal-article","created":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T09:01:47Z","timestamp":1783674107000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Efficient in vivo cytosine base editing using virus-like particles with uracil DNA glycosylase inhibition"],"prefix":"10.1038","author":[{"given":"Junjie","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai-Ming","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingyu","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jifang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Buer","family":"Ha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bao-Qing","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xujiao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengfang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuangyu","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenchao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyun","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-5449-712X","authenticated-orcid":false,"given":"Xiaodun","family":"Mou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5389-3859","authenticated-orcid":false,"given":"Bei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9912-633X","authenticated-orcid":false,"given":"Jiaxu","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8833-7473","authenticated-orcid":false,"given":"Li","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4242-2899","authenticated-orcid":false,"given":"Jia","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,10]]},"reference":[{"key":"3227_CR1","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.cell.2020.03.023","volume":"181","author":"D Wang","year":"2020","unstructured":"Wang, D., Zhang, F. & Gao, G. CRISPR-based therapeutic genome editing: strategies and in vivo delivery by AAV vectors. Cell 181, 136\u2013150 (2020).","journal-title":"Cell"},{"key":"3227_CR2","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/s41556-021-00671-4","volume":"23","author":"L Wang","year":"2021","unstructured":"Wang, L. et al. Eliminating base-editor-induced genome-wide and transcriptome-wide off-target mutations. Nat. Cell Biol. 23, 552\u2013563 (2021).","journal-title":"Nat. Cell Biol."},{"key":"3227_CR3","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/mt.2009.255","volume":"18","author":"Z Wu","year":"2010","unstructured":"Wu, Z., Yang, H. & Colosi, P. Effect of genome size on AAV vector packaging. Mol Ther 18, 80\u201386 (2010).","journal-title":"Mol Ther"},{"key":"3227_CR4","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.omtm.2017.11.007","volume":"8","author":"P Colella","year":"2018","unstructured":"Colella, P., Ronzitti, G. & Mingozzi, F. Emerging issues in AAV-mediated in vivo gene therapy. Mol. Ther. Methods Clin. Dev. 8, 87\u2013104 (2018).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"3227_CR5","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1182\/blood-2019-126007","volume":"134","author":"GN Nguyen","year":"2019","unstructured":"Nguyen, G. N. et al. Long-term AAV-mediated factor VIII expression in nine hemophilia A dogs: a 10 year follow-up analysis on durability, safety and vector integration. Blood 134, 611\u2013611 (2019).","journal-title":"Blood"},{"key":"3227_CR6","doi-asserted-by":"publisher","first-page":"7835","DOI":"10.1021\/acsnano.4c14041","volume":"19","author":"Q Chen","year":"2025","unstructured":"Chen, Q. et al. Targeted delivery of mRNA with polymer\u2013lipid nanoparticles for in vivo base editing. ACS Nano 19, 7835\u20137850 (2025).","journal-title":"ACS Nano"},{"key":"3227_CR7","doi-asserted-by":"publisher","first-page":"2806","DOI":"10.1016\/j.cell.2022.03.045","volume":"185","author":"A Raguram","year":"2022","unstructured":"Raguram, A., Banskota, S. & Liu, D. R. Therapeutic in vivo delivery of gene editing agents. Cell 185, 2806\u20132827 (2022).","journal-title":"Cell"},{"key":"3227_CR8","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/s41573-019-0012-9","volume":"18","author":"D Wang","year":"2019","unstructured":"Wang, D., Tai, P. W. & Gao, G. Adeno-associated virus vector as a platform for gene therapy delivery. Nat. Rev. Drug Discov. 18, 358\u2013378 (2019).","journal-title":"Nat. Rev. Drug Discov."},{"key":"3227_CR9","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.cell.2021.12.021","volume":"185","author":"S Banskota","year":"2022","unstructured":"Banskota, S. et al. Engineered virus-like particles for efficient in vivo delivery of therapeutic proteins. Cell 185, 250\u2013265 (2022).","journal-title":"Cell"},{"key":"3227_CR10","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/s41565-024-01851-7","volume":"20","author":"S Ling","year":"2025","unstructured":"Ling, S. et al. Customizable virus-like particles deliver CRISPR\u2013Cas9 ribonucleoprotein for effective ocular neovascular and Huntington\u2019s disease gene therapy. Nat. Nanotechnol. 20, 543\u2013553 (2025).","journal-title":"Nat. Nanotechnol."},{"key":"3227_CR11","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.1016\/j.cell.2023.03.033","volume":"186","author":"SM Hindi","year":"2023","unstructured":"Hindi, S. M. et al. Enveloped viruses pseudotyped with mammalian myogenic cell fusogens target skeletal muscle for gene delivery. Cell 186, 2062\u20132077 (2023).","journal-title":"Cell"},{"key":"3227_CR12","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/s41551-020-00656-y","volume":"5","author":"S Ling","year":"2021","unstructured":"Ling, S. et al. Lentiviral delivery of co-packaged Cas9 mRNA and a Vegfa-targeting guide RNA prevents wet age-related macular degeneration in mice. Nat. Biomed. Eng. 5, 144\u2013156 (2021).","journal-title":"Nat. Biomed. Eng."},{"key":"3227_CR13","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1038\/s41587-023-02085-z","volume":"42","author":"JR Hamilton","year":"2024","unstructured":"Hamilton, J. R. et al. In vivo human T cell engineering with enveloped delivery vehicles. Nat. Biotechnol. 42, 1684\u20131692 (2024).","journal-title":"Nat. Biotechnol."},{"key":"3227_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.edisc.2026.100040","volume":"2","author":"L Kong","year":"2026","unstructured":"Kong, L. et al. Precision engineering for ocular gene therapy: molecular tools, delivery platforms, and disease applications. Eye Discov. 2, 100040 (2026).","journal-title":"Eye Discov."},{"key":"3227_CR15","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1038\/s41576-018-0059-1","volume":"19","author":"HA Rees","year":"2018","unstructured":"Rees, H. A. & Liu, D. R. Base editing: precision chemistry on the genome and transcriptome of living cells. Nat. Rev. Genet. 19, 770\u2013788 (2018).","journal-title":"Nat. Rev. Genet."},{"key":"3227_CR16","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1038\/s41587-020-0561-9","volume":"38","author":"AV Anzalone","year":"2020","unstructured":"Anzalone, A. V., Koblan, L. W. & Liu, D. R. Genome editing with CRISPR\u2013Cas nucleases, base editors, transposases and prime editors. Nat. Biotechnol. 38, 824\u2013844 (2020).","journal-title":"Nat. Biotechnol."},{"key":"3227_CR17","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1038\/nature17946","volume":"533","author":"AC Komor","year":"2016","unstructured":"Komor, A. C., Kim, Y. B., Packer, M. S., Zuris, J. A. & Liu, D. R. Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage. Nature 533, 420\u2013424 (2016).","journal-title":"Nature"},{"key":"3227_CR18","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1038\/nbt.4102","volume":"36","author":"X Li","year":"2018","unstructured":"Li, X. et al. Base editing with a Cpf1\u2013cytidine deaminase fusion. Nat. Biotechnol. 36, 324\u2013327 (2018).","journal-title":"Nat. Biotechnol."},{"key":"3227_CR19","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1038\/nbt.4198","volume":"36","author":"X Wang","year":"2018","unstructured":"Wang, X. et al. Efficient base editing in methylated regions with a human APOBEC3A\u2013Cas9 fusion. Nat. Biotechnol. 36, 946\u2013949 (2018).","journal-title":"Nat. Biotechnol."},{"key":"3227_CR20","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/nature24644","volume":"551","author":"NM Gaudelli","year":"2017","unstructured":"Gaudelli, N. M. et al. Programmable base editing of A\u2022T to G\u2022C in genomic DNA without DNA cleavage. Nature 551, 464\u2013471 (2017).","journal-title":"Nature"},{"key":"3227_CR21","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1038\/s41587-023-01994-3","volume":"42","author":"YL Xiao","year":"2024","unstructured":"Xiao, Y. L., Wu, Y. & Tang, W. An adenine base editor variant expands context compatibility. Nat. Biotechnol. 42, 1442\u20131453 (2024).","journal-title":"Nat. Biotechnol."},{"key":"3227_CR22","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/s41576-022-00541-1","volume":"24","author":"PJ Chen","year":"2023","unstructured":"Chen, P. J. & Liu, D. R. Prime editing for precise and highly versatile genome manipulation. Nat. Rev. Genet. 24, 161\u2013177 (2023).","journal-title":"Nat. Rev. Genet."},{"key":"3227_CR23","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/s41586-019-1711-4","volume":"576","author":"AV Anzalone","year":"2019","unstructured":"Anzalone, A. V. et al. Search-and-replace genome editing without double-strand breaks or donor DNA. Nature 576, 149\u2013157 (2019).","journal-title":"Nature"},{"key":"3227_CR24","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/s41587-020-0677-y","volume":"39","author":"HK Kim","year":"2021","unstructured":"Kim, H. K. et al. Predicting the efficiency of prime editing guide RNAs in human cells. Nat. Biotechnol. 39, 198\u2013206 (2021).","journal-title":"Nat. Biotechnol."},{"key":"3227_CR25","doi-asserted-by":"publisher","first-page":"2256","DOI":"10.1016\/j.cell.2023.03.034","volume":"186","author":"G Yu","year":"2023","unstructured":"Yu, G. et al. Prediction of efficiencies for diverse prime editing systems in multiple cell types. Cell 186, 2256\u20132272 (2023).","journal-title":"Cell"},{"key":"3227_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-29339-9","volume":"13","author":"X Li","year":"2022","unstructured":"Li, X. et al. Highly efficient prime editing by introducing same-sense mutations in pegRNA or stabilizing its structure. Nat. Commun. 13, 1669 (2022).","journal-title":"Nat. Commun."},{"key":"3227_CR27","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1038\/s41587-024-02467-x","volume":"43","author":"A Raguram","year":"2025","unstructured":"Raguram, A., An, M., Chen, P. Z. & Liu, D. R. Directed evolution of engineered virus-like particles with improved production and transduction efficiencies. Nat. Biotechnol. 43, 1635\u20131647 (2025).","journal-title":"Nat. Biotechnol."},{"key":"3227_CR28","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1038\/s41587-023-02078-y","volume":"42","author":"M An","year":"2024","unstructured":"An, M. et al. Engineered virus-like particles for transient delivery of prime editor ribonucleoprotein complexes in vivo. Nat. Biotechnol. 42, 1526\u20131537 (2024).","journal-title":"Nat. Biotechnol."},{"key":"3227_CR29","doi-asserted-by":"publisher","first-page":"2637","DOI":"10.1016\/j.cell.2025.03.015","volume":"188","author":"J Geilenkeuser","year":"2025","unstructured":"Geilenkeuser, J. et al. Engineered nucleocytosolic vehicles for loading of programmable editors. Cell 188, 2637\u20132655 (2025).","journal-title":"Cell"},{"key":"3227_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-60789-z","volume":"16","author":"H-Y Hwang","year":"2025","unstructured":"Hwang, H.-Y. et al. Engineered Sdd7 cytosine base editors with enhanced specificity. Nat. Commun. 16, 5881 (2025).","journal-title":"Nat. Commun."},{"key":"3227_CR31","doi-asserted-by":"publisher","first-page":"3194","DOI":"10.1038\/s41596-023-00877-w","volume":"18","author":"W Han","year":"2023","unstructured":"Han, W. et al. Design and application of the transformer base editor in mammalian cells and mice. Nat. Protoc. 18, 3194\u20133228 (2023).","journal-title":"Nat. Protoc."},{"key":"3227_CR32","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1016\/j.stem.2023.10.007","volume":"30","author":"W Han","year":"2023","unstructured":"Han, W. et al. Base editing of the HBG promoter induces potent fetal hemoglobin expression with no detectable off-target mutations in human HSCs. Cell Stem Cell 30, 1624\u20131639 (2023).","journal-title":"Cell Stem Cell"},{"key":"3227_CR33","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1038\/s41586-026-10342-9","volume":"653","author":"Y Lai","year":"2026","unstructured":"Lai, Y. et al. Clinical application of base editing for treating \u03b2-thalassaemia. Nature 653, 923\u2013932 (2026).","journal-title":"Nature"},{"key":"3227_CR34","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1038\/s41587-025-02678-w","volume":"44","author":"Y Wu","year":"2026","unstructured":"Wu, Y., Xiao, Y.-L. & Tang, W. High-precision cytosine base editors by evolving nucleic-acid-recognition hotspots in deaminase. Nat. Biotechnol. 44, 587\u2013601 (2026).","journal-title":"Nat. Biotechnol."},{"key":"3227_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-07845-z","volume":"10","author":"PE Mangeot","year":"2019","unstructured":"Mangeot, P. E. et al. Genome editing in primary cells and in vivo using viral-derived nanoblades loaded with Cas9\u2013sgRNA ribonucleoproteins. Nat. Commun. 10, 45 (2019).","journal-title":"Nat. Commun."},{"key":"3227_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01690-3","volume":"9","author":"X Bao","year":"2024","unstructured":"Bao, X. et al. Targeting proprotein convertase subtilisin\/kexin type 9 (PCSK9): from bench to bedside. Signal Transduct. Target. Ther. 9, 13 (2024).","journal-title":"Signal Transduct. Target. Ther."},{"key":"3227_CR37","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1146\/annurev-biochem-013118-111315","volume":"88","author":"WA Beard","year":"2019","unstructured":"Beard, W. A., Horton, J. K., Prasad, R. & Wilson, S. H. Eukaryotic base excision repair: new approaches shine light on mechanism. Annu. Rev. Biochem. 88, 137\u2013162 (2019).","journal-title":"Annu. Rev. Biochem."},{"key":"3227_CR38","doi-asserted-by":"publisher","first-page":"22158","DOI":"10.1073\/pnas.1904024116","volume":"116","author":"AA Serebrenik","year":"2019","unstructured":"Serebrenik, A. A. et al. The deaminase APOBEC3B triggers the death of cells lacking uracil DNA glycosylase. Proc. Natl Acad. Sci. USA 116, 22158\u201322163 (2019).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"3227_CR39","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aao4774","volume":"3","author":"AC Komor","year":"2017","unstructured":"Komor, A. C. et al. Improved base excision repair inhibition and bacteriophage Mu Gam protein yields C:G-to-T:A base editors with higher efficiency and product purity. Sci. Adv. 3, eaao4774 (2017).","journal-title":"Sci. Adv."},{"key":"3227_CR40","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1038\/cr.2017.111","volume":"27","author":"L Wang","year":"2017","unstructured":"Wang, L. et al. Enhanced base editing by co-expression of free uracil DNA glycosylase inhibitor. Cell Res. 27, 1289\u20131292 (2017).","journal-title":"Cell Res."},{"key":"3227_CR41","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/0092-8674(95)90467-0","volume":"82","author":"CD Mol","year":"1995","unstructured":"Mol, C. D. et al. Crystal structure of human uracil-DNA glycosylase in complex with a protein inhibitor: protein mimicry of DNA. Cell 82, 701\u2013708 (1995).","journal-title":"Cell"},{"key":"3227_CR42","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/nbt.2884","volume":"32","author":"H Yin","year":"2014","unstructured":"Yin, H. et al. Genome editing with Cas9 in adult mice corrects a disease mutation and phenotype. Nat. Biotechnol. 32, 551\u2013553 (2014).","journal-title":"Nat. Biotechnol."},{"key":"3227_CR43","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1038\/s41589-024-01595-4","volume":"20","author":"L Yang","year":"2024","unstructured":"Yang, L. et al. Engineering APOBEC3A deaminase for highly accurate and efficient base editing. Nat. Chem. Biol. 20, 1176\u20131187 (2024).","journal-title":"Nat. Chem. Biol."},{"key":"3227_CR44","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41594-017-0004-6","volume":"25","author":"L Lei","year":"2018","unstructured":"Lei, L. et al. APOBEC3 induces mutations during repair of CRISPR\u2013Cas9-generated DNA breaks. Nat. Struct. Mol. Biol. 25, 45\u201352 (2018).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"3227_CR45","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1128\/MCB.00030-16","volume":"36","author":"RJ Carter","year":"2016","unstructured":"Carter, R. J. & Parsons, J. L. Base excision repair, a pathway regulated by posttranslational modifications. Mol. Cell. Biol. 36, 1426\u20131437 (2016).","journal-title":"Mol. Cell. Biol."},{"key":"3227_CR46","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1038\/nbt.3526","volume":"34","author":"H Ma","year":"2016","unstructured":"Ma, H. et al. Multiplexed labeling of genomic loci with dCas9 and engineered sgRNAs using CRISPRainbow. Nat. Biotechnol. 34, 528\u2013530 (2016).","journal-title":"Nat. Biotechnol."},{"key":"3227_CR47","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.cell.2014.11.052","volume":"160","author":"JG Zalatan","year":"2015","unstructured":"Zalatan, J. G. et al. Engineering complex synthetic transcriptional programs with CRISPR RNA scaffolds. Cell 160, 339\u2013350 (2015).","journal-title":"Cell"},{"key":"3227_CR48","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1126\/science.aba8853","volume":"368","author":"RT Walton","year":"2020","unstructured":"Walton, R. T., Christie, K. A., Whittaker, M. N. & Kleinstiver, B. P. Unconstrained genome targeting with near-PAMless engineered CRISPR\u2013Cas9 variants. Science 368, 290\u2013296 (2020).","journal-title":"Science"},{"key":"3227_CR49","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/s41587-022-01533-6","volume":"41","author":"ME Neugebauer","year":"2023","unstructured":"Neugebauer, M. E. et al. Evolution of an adenine base editor into a small, efficient cytosine base editor with low off-target activity. Nat. Biotechnol. 41, 673\u2013685 (2023).","journal-title":"Nat. Biotechnol."},{"key":"3227_CR50","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/s41586-019-1314-0","volume":"571","author":"C Zhou","year":"2019","unstructured":"Zhou, C. et al. Off-target RNA mutation induced by DNA base editing and its elimination by mutagenesis. Nature 571, 275\u2013278 (2019).","journal-title":"Nature"},{"key":"3227_CR51","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1038\/gim.2017.101","volume":"19","author":"JM Chinsky","year":"2017","unstructured":"Chinsky, J. M. et al. Diagnosis and treatment of tyrosinemia type I: a US and Canadian consensus group review and recommendations. Genet. Med. 19, 1380\u20131395 (2017).","journal-title":"Genet. Med."},{"key":"3227_CR52","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-021-01879-1","volume":"16","author":"D Gonz\u00e1lez-Lamu\u00f1o","year":"2021","unstructured":"Gonz\u00e1lez-Lamu\u00f1o, D., S\u00e1nchez-Pintos, P., Andrade, F., Couce, M. L. & Ald\u00e1miz-Echevarr\u00eda, L. Treatment adherence in tyrosinemia type 1 patients. Orphanet J. Rare Dis. 16, 256 (2021).","journal-title":"Orphanet J. Rare Dis."},{"key":"3227_CR53","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/nrgastro.2018.11","volume":"15","author":"CQ Song","year":"2018","unstructured":"Song, C. Q. & Xue, W. CRISPR\u2013Cas-related technologies in basic and translational liver research. Nat. Rev. Gastroenterol. Hepatol. 15, 251\u2013252 (2018).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"3227_CR54","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.01482","volume":"10","author":"L Meunier","year":"2019","unstructured":"Meunier, L. & Larrey, D. Drug-induced liver injury: biomarkers, requirements, candidates, and validation. Front. Pharmacol. 10, 1482 (2019).","journal-title":"Front. Pharmacol."},{"key":"3227_CR55","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1038\/s41580-023-00631-w","volume":"24","author":"L P\u00e9rez-Guti\u00e9rrez","year":"2023","unstructured":"P\u00e9rez-Guti\u00e9rrez, L. & Ferrara, N. Biology and therapeutic targeting of vascular endothelial growth factor A. Nat. Rev. Mol. Cell Biol. 24, 816\u2013834 (2023).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"3227_CR56","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1038\/nprot.2013.135","volume":"8","author":"V Lambert","year":"2013","unstructured":"Lambert, V. et al. Laser-induced choroidal neovascularization model to study age-related macular degeneration in mice. Nat. Protoc. 8, 2197\u20132211 (2013).","journal-title":"Nat. Protoc."},{"key":"3227_CR57","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1383","volume":"13","author":"S Hu","year":"2023","unstructured":"Hu, S. et al. Nme2Cas9-mediated therapeutic editing in inhibiting angiogenesis after wet age-related macular degeneration onset. Clin. Transl. Med. 13, e1383 (2023).","journal-title":"Clin. Transl. Med."},{"key":"3227_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.114973","volume":"43","author":"R Guo","year":"2024","unstructured":"Guo, R. et al. Engineered IscB\u2013\u03c9RNA system with improved base editing efficiency for disease correction via single AAV delivery in mice. Cell Rep. 43, 114973 (2024).","journal-title":"Cell Rep."},{"key":"3227_CR59","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-45197-z","volume":"15","author":"Z Li","year":"2024","unstructured":"Li, Z. et al. Engineering a transposon-associated TnpB\u2013\u03c9RNA system for efficient gene editing and phenotypic correction of a tyrosinaemia mouse model. Nat. Commun. 15, 831 (2024).","journal-title":"Nat. Commun."},{"key":"3227_CR60","doi-asserted-by":"publisher","first-page":"14082","DOI":"10.1073\/pnas.93.24.14082","volume":"93","author":"PD Kessler","year":"1996","unstructured":"Kessler, P. D. et al. Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic protein. Proc. Natl Acad. Sci. USA 93, 14082\u201314087 (1996).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"3227_CR61","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/s41551-024-01296-2","volume":"9","author":"R Ho\u0142ubowicz","year":"2025","unstructured":"Ho\u0142ubowicz, R. et al. Safer and efficient base editing and prime editing via ribonucleoproteins delivered through optimized lipid-nanoparticle formulations. Nat. Biomed. Eng. 9, 57\u201378 (2025).","journal-title":"Nat. Biomed. Eng."},{"key":"3227_CR62","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/s41551-024-01208-4","volume":"9","author":"D Yin","year":"2025","unstructured":"Yin, D. et al. Dendritic-cell-targeting virus-like particles as potent mRNA vaccine carriers. Nat. Biomed. Eng. 9, 185\u2013200 (2025).","journal-title":"Nat. Biomed. Eng."},{"key":"3227_CR63","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-40788-8","volume":"14","author":"D Strebinger","year":"2023","unstructured":"Strebinger, D. et al. Cell type-specific delivery by modular envelope design. Nat. Commun. 14, 5141 (2023).","journal-title":"Nat. Commun."},{"key":"3227_CR64","doi-asserted-by":"publisher","unstructured":"Botchkarev, V. V. Jr. et al. In vivo gene editing of human hematopoietic stem and progenitor cells using envelope-engineered virus-like particles. Nat. Biotechnol. https:\/\/doi.org\/10.1038\/s41587-025-02915-2 (2025).","DOI":"10.1038\/s41587-025-02915-2"},{"key":"3227_CR65","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01600-19","volume":"94","author":"TM Renner","year":"2020","unstructured":"Renner, T. M., Tang, V. A., Burger, D. & Langlois, M.-A. Intact viral particle counts measured by flow virometry provide insight into the infectivity and genome packaging efficiency of Moloney murine leukemia virus. J. Virol. 94, e01600-19 (2020).","journal-title":"J. Virol."},{"key":"3227_CR66","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1093\/bioinformatics\/btu048","volume":"30","author":"S Bae","year":"2014","unstructured":"Bae, S., Park, J. & Kim, J.-S. Cas-OFFinder: a fast and versatile algorithm that searches for potential off-target sites of Cas9 RNA-guided endonucleases. Bioinformatics 30, 1473\u20131475 (2014).","journal-title":"Bioinformatics"},{"key":"3227_CR67","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-12281-8","volume":"10","author":"D Wang","year":"2019","unstructured":"Wang, D. et al. Optimized CRISPR guide RNA design for two high-fidelity Cas9 variants by deep learning. Nat. Commun. 10, 4284 (2019).","journal-title":"Nat. Commun."},{"key":"3227_CR68","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/s41586-021-03534-y","volume":"593","author":"K Musunuru","year":"2021","unstructured":"Musunuru, K. et al. In vivo CRISPR base editing of PCSK9 durably lowers cholesterol in primates. Nature 593, 429\u2013434 (2021).","journal-title":"Nature"},{"key":"3227_CR69","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.107723","volume":"31","author":"X Wang","year":"2020","unstructured":"Wang, X. et al. Cas12a base editors induce efficient and specific editing with low DNA damage response. Cell Rep. 31, 107723 (2020).","journal-title":"Cell Rep."}],"container-title":["Nature Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41587-026-03227-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41587-026-03227-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41587-026-03227-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T09:01:49Z","timestamp":1783674109000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41587-026-03227-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,10]]},"references-count":69,"alternative-id":["3227"],"URL":"https:\/\/doi.org\/10.1038\/s41587-026-03227-9","relation":{},"ISSN":["1087-0156","1546-1696"],"issn-type":[{"value":"1087-0156","type":"print"},{"value":"1546-1696","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,10]]},"assertion":[{"value":"30 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.C., L.Y. and B.Y. are scientific cofounders of CorrectSequence Therapeutics (a company that uses gene-editing technologies) and members of its scientific advisory board. J.C., L.Y., B.Y., J.Z., L.D. and J.L. have filed patent applications related to the published work through ShanghaiTech University. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}